SEC Form 4 · accession 0001213900-15-009537
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maged Shenouda
Director
Period of report
Dec 15, 2015
Accepted (ET)
Dec 17, 2015 · 9:37 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 15, 2015 | P | 2,000 | $2.98 | A | 4,000 | D | |
| Common stock | Dec 15, 2015 | P | 241 | $2.99 | A | 4,241 | D | |
| Common stock | Dec 15, 2015 | P | 759 | $3.00 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.